Bergner et al.
JOCArticle
J = 17.3, 6.4, 1.5 Hz, H-4b); 13C NMR, DEPT (75.5 MHz,
CDCl3) δ=177.7 (CdN), 138.6, 132.7 (C-10, C-100), 131.9 (1C),
128.9 (2C), 128.8 (2C), 128.1 (2C), 128.0 (1C), 127.5 (2C,
phenyl), 117.0 (CN), 67.3 (C-2), 46.1 (C-3), 42.4 (C-4); FD-
MS (m/z) = 246.1 (100) [M]þ. Anal. Calcd for C17H14N2
(246.31): C, 82.90; H, 5.73; N, 11.37. Found: C, 82.71; H,
5.70; N, 11.06.
(C-40), 68.5 (C-2), 48.7 (C-3), 43.5 (C-4); ESI-MS m/z (%) =
543.3 [2M þ H]þ (7), 313.1 [M þ H þ MeCN]þ (11), 272.1 [M þ
H]þ (62), 245.1 [M - CN]þ (100); ESI-HRMS calcd for [C18H13-
N3 þ H]þ 272.1188; found 272.1180.
cis-Isomer: IR (film) ν=3156, 2927, 2360, 2341, 2254, 2232,
1
1611, 1345, 1062, 908 cm-1. H NMR (300 MHz, CDCl3) δ=
7.89 (mc, 2H, H-200,600), 7.63 (mc, 2H, H-20,60), 7.44-7.57 (m,
3H, H-300,400,500), 7.34 (mc, 2H, H-30,50), 5.36 (dt, 1H, Jd=8.2 Hz,
Jt=1.5 Hz, H-2), 4.02 (d-pseudo-t, 1H, Jt ≈ 8 Hz, Jd=5.7 Hz, H-
3), 3.57 (ddd, 1H, J=17.4, 8.5, 1.5 Hz, H-4a), 3.40 (ddd, 1H, J=
17.4, 5.7, 1.5 Hz, H-4b); 13C NMR (75.5 MHz, CDCl3) δ=177.3
(C-5), 144.2 (C-10), 132.7 (C-30,50), 132.2 (C-400, 100), 128.8 (2C),
128.4 (2C), 128.2 (2C) (C-40,60, C-200,600, C-300,500), 118.4 (CN),
116.6 (CN), 112.0 (C-40), 67.0 (C-2), 46.0 (C-3), 42.5 (C-4); ESI-
MS m/z (%)=272.1 [M þ H]þ (24), 245.1 [M - CN]þ (100); ESI-
HRMS calcd for [C18H13N3 þ H]þ 272.1188; found 272.1186.
5-(4-Chlorophenyl)-3-(3-nitrophenyl)-3,4-dihydro-2H-pyrrole-
2-carbonitrile (3d). The title compound was prepared according
to the general procedure from aminoacetonitrile hydrochloride
(192 mg, 2.07 mmol), 40-chloro-3-nitrochalcone (397 mg, 1.38
mmol), and pyridine (5.8 mL). After 3 h, TLC indicated in-
complete conversion, and another portion of aminoaceto-
nitrile hydrochloride (65 mg, 0.70 mmol) was added. After
another 2 h, workup yielded a black oil (560 mg). Ratio of
isomers: trans/cis=2.6:1. Purification of the crude product by
flash chromatography (cyclohexane/ethyl acetate, 5:1) gave
trans-3d as yellow crystals (277 mg, 0.85 mmol, 62%), mp
169.5-170.5 °C (dec), Rf (cyclohexane/ethyl acetate 2:1) =
0.38 and cis-3d as orange crystals (80 mg, 0.38 mmol, 28%),
mp 178-179 °C (dec), Rf (cyclohexane/ethyl acetate 2:1)=0.15.
trans-Isomer: IR (film) ν=2958, 2919, 1611, 1597, 1530, 1351,
1093, 906, 735 cm-1; 1H NMR (400 MHz, CDCl3) 8.19 (dt, Jd=
7.7 Hz, Jt=1.7 Hz, 1H, H-40), 8.14 (t, J=1.7 Hz, 1H, H-20), 7.83
(AA0-part of AA0BB0-system, 2H, H-200,600), 7.62 (d, Jd=7.7 Hz,
1H, H-60), 7.59 (t, Jt =7.8 Hz, 1H, H-50), 7.44 (BB0-part of a
AA0BB0-system, 2H, H-300,500), 4.93 (dt, Jd=7.3 Hz, Jt=1.6 Hz,
1H, H-2), 4.06 (d-pseudo-t, Jd=9.2 Hz, Jt ≈ 7 Hz, 1H, H-3), 3.73
(ddd, J=17.2, 9.2, 1.6 Hz, 1H, H-4a), 3.25 (ddd, J=17.2, 7.7, 1.6
Hz, 1H, H-4b);13C NMR (400 MHz, CDCl3) δ=175.5 (C-5),
149.1 (aryl-Cq), 142.0 (aryl-Cq), 138.8 (aryl-Cq), 133.4 (aryl-
CH), 131.0 (aryl-Cq) 130.7 (aryl-CH), 129.8 (C-20,60), 129.4 (C-
30, 50), 123.3 (aryl-CH), 121.8 (aryl-CH), 118.6 (CN), 68.9 (C-2),
48.9 (C-3), 43.7 (C-4); FAB-MS (m/z) 325 (100) [M]þ, 176 (94);
ESI-HRMS calcd for [C17H12ClN3O2 þ H]þ 326.0696, found
326.0692.
5-(4-Fluorophenyl)-3-(4-methoxyphenyl)-3,4-dihydro-2H-pyr-
role-2-carbonitrile (3b). The title compound was prepared ac-
cording to the general procedure from aminoacetonitrile
hydrochloride (108 mg, 1.17 mmol), 4-methoxy-40-fluorochal-
cone (197 mg, 0.77 mmol), and pyridine (3.2 mL). After 19 h,
TLC did not indicate complete conversion, and another portion
of aminoacetonitrile hydrochloride (36 mg, 0.39 mmol) was
added. After another 21 h, workup produced a black oil (237
mg). Ratio of isomers: trans/cis=2.9:1. Purification of the crude
product by flash chromatography (cyclohexane/ethyl acetate,
10:1 þ 1% EtNMe2) gave trans-3c as a yellow oil (95 mg, 42%):
Rf (cyclohexane/ethyl acetate 10:1)=0.20 and cis-3c as a yellow
oil (26 mg, 11%), Rf (cyclohexane/ethyl acetate 10:1)=0.06.
trans-Isomer: IR (film) ν=3005, 2936, 2838, 2245, 1603, 1513,
1253, 1034, 838 cm-1; 1H NMR (300 MHz, CDCl3) δ=7.90 (mc,
2H, H-30,50), 7.11-7.21 (m, 4H, H-20,60, H-400,600), 6.90 (mc, 2H,
H-300,500), 4.86 (dt, 1H, Jd=7.1 Hz, Jt=1.9 Hz, H-2), 3.90 (d-
pseudo-t, 1H, Jd=9.4 Hz, Jt ≈ 7 Hz, H-3), 3.81 (s, 3H, OCH3),
3.63 (ddd, 1H, J=17.3, 9.4, 1.9 Hz, H-4a), 3.19 (ddd, 1H, J=
17.3, 7.4, 1.9 Hz, H-4b); 13C NMR (75.6 MHz, CDCl3) δ=175.4
(C-5), 166.5 (1JC,F=253.7 Hz, C-40), 159.1 (C-400), 131.8 (C-100),
130.4 (3JC,F=8.8 Hz, C-20,60), 129.1 (4JC,F=3.2 Hz, C-10), 127.7
(C-200, 600), 119.2 (CN), 115.8 (2JC,F=21.9 Hz, C-30, 50), 114.5 (C-
300, 500), 69.0 (C-2), 55.3 (OCH3), 48.3 (C-3), 43.7 (C-4); ESI-MS
m/z=336.1 [M þ H þ MeCN]þ (7), 295.1 [M þ H]þ (100), 268.0
[M - CN]þ (32); ESI-HRMS calcd for [C18H15FN2O þ H]þ
295.1247, found 295.1240.
1
cis-Isomer: H NMR (300 MHz, CDCl3) δ=8.02 (mc, 2H,
H-30,50), 7.36 (mc, 2H, H-20,60), 7.18 (mc, 2H, H-400,600), 6.91 (mc,
2H, H-300,500), 5.60 (br d, 1H, J=8.1 Hz, H-2), 3.98 (d-pseudo-t,
1H, Jt ≈ 8 Hz, Jd=6.3 Hz, H-3), 3.73 (s, 3H, OCH3), 3.52 (ddd,
2H, J=17.4, 8.5, 1.2 Hz, H-4a), 3.38 (ddd, 1H, J=17.4, 6.3, 1.2
Hz, 4b); 13C NMR (75.5 MHz, CDCl3) δ=176.6 (C-5), 164.3
(1JC,F = 249.7 Hz, C-40), 158.6 (C-400), 131.7 (C-100), 130.8
(3JC,F=9.0 Hz, C-20,60), 129.6 (4JC,F=3.0 Hz, C-10), 128.8 (C-
200, 600), 118.2 (CN), 116.0 (2JC,F=21.9 Hz, C-30, 50), 114.0 (C-300,
500), 66.9 (C-2), 55.1 (OCH3), 44.5 (C-3), 41.9 (C-4); ESI-MS
m/z=317.1 [M þ K]þ (20), 295.1 [M þ H]þ (20), 273.2 (100);
ESI-HRMS calcd for [C18H15FN2O þ H]þ 295.1247, found
295.1238.
cis-Isomer: IR (film) ν=2927, 1605, 1597, 1529, 1348, 1093,
907, 731 cm-1; 1H NMR (400 MHz, CDCl3) δ=8.18 (dt, Jt=2.3,
Hz, Jd=6.4 Hz, 1H, H-40), 8.11 (br s, 1H, H-20), 7.86 (mc, part of
a AA0BB0-system, 2H, H-200,600), 7.54-7.59 (m, 2H, H-50, 60),
7.47 (mc, part of a AA0BB0-system, 2H, H-300,500), 5.38 (dt, Jd=
8.4 Hz, Jt=1.5 Hz, 1H, H-2), 4.09 (d-pseudo-t, Jt ≈ 9 Hz, Jd=6.2
Hz, 1H, H-3), 3.57 (ddd, J=17.3, 8.8, 1.1 Hz, 1H, H-4a), 3.41
(ddd, J=17.3, 6.2, 1.1 Hz, 1H, H-4b); 13C NMR (101 MHz,
CDCl3) δ=176.5 (C-5), 148.6 (C-30), 140.8 (aryl-Cq), 138.9 (aryl-
Cq), 133.7 (aryl-CH), 131.0 (aryl-Cq), 130.4 (aryl-CH), 129.8 (C-
200,600), 129.5 (C-300,500), 123.5 (aryl-CH), 123.0 (aryl-CH), 116.6
(CN), 67.3 (C-2), 46.1 (C-3), 42.6 (C-4); FAB-MS (m/z) 326 (84)
[M þ H]þ, 178 (100); ESI-HRMS calcd for [C17H12ClN3O2 þ
Na]þ 348.0516, found 348.0519. Anal. Calcd for C17H12ClN3O2
(325.75): C, 62.68; H, 3.71; N, 12.90. Found: C, 62.35; H, 3.45;
N, 12.83.
5-Phenyl-3-(4-cyanophenyl)-3,4-dihydro-2H-pyrrole-2-carbo-
nitrile (3c). The title compound was prepared according to
the general procedure from aminoacetonitrile hydrochloride
(166 mg, 1.82 mmol), 4-cyanochalcone32 (205 mg, 0.88 mmol),
and pyridine (3.2 mL) in 17 h. Workup yielded a black oil
(245 mg). Ratio of isomers: trans/cis=2.4:1. Purification of the
crude product by flash chromatography (cyclohexane/ethyl
acetate, 10:1) gave trans-3c as a yellow oil (95 mg, 40%), Rf
(cyclohexane/ethyl acetate 10:1)=0.24 and cis-3c as a yellow oil
(32 g, 13%), Rf (cyclohexane/ethyl acetate 10:1)=0.09.
trans-Isomer: IR (film) ν=3068, 2926, 2360, 2341, 2254, 2232,
1
1612, 1345, 1074, 909 cm-1; H NMR (300 MHz, CDCl3) δ=
7.86 (mc, 2H, H-200,600), 7.65 (mc, 2H, H-20,60), 7.43-7.56 (m,
3H, H-300,400,500), 7.38 (mc, 2H, H-30,50), 4.92 (dt, 1H, Jd=7.0 Hz,
Jt=1.7 Hz, H-2), 4.00 (d-pseudo-t, 1H, Jd=9.5 Hz, Jt ≈ 7 Hz, H-
3), 3.74 (ddd, 1H, J=17.4, 9.5, 1.7 Hz, H-4a), 3.25 (ddd, 1H, J=
17.4, 7.4, 1.7 Hz, H-4b); 13C NMR (75.5 MHz, DMSO) δ=176.4
(C-5), 145.3 (C-10), 133.0 (C-30,50), 132.2 (C-400, C-100), 128.8
(2C), 128.2 (2C), 127.6 (2C), 118.5 (CN), 118.2 (CN), 111.9
5-(2-Naphthyl)-3-phenyl-3,4-dihydro-2H-pyrrole-2-carbo-
nitrile (3e). The title compound was prepared according to
the general procedure from aminoacetonitrile hydrochloride
(173 mg, 1.87 mmol), (E)-1-(2-naphthyl)-3-phenylpropenone33
(33) Robinson, T. P.; Hubbard, R. B.; Ehlers, T. J.; Arbiser, J. L.;
Goldsmith, D. J.; Bowen, J. P. Bioorg. Med. Chem. 2005, 13, 4007–4013.
(32) MacClean, I. S.; Widdows, S. T. J. Chem. Soc. 1914, 105, 2169–2175.
J. Org. Chem. Vol. 74, No. 21, 2009 8247